[{"Assets_0_Q2_USD":1747753000.0,"CommonStockSharesOutstanding_0_Q2_shares":74327767.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-225237000.0,"NetIncomeLoss_1_Q2_USD":-276403000.0,"NetIncomeLoss_2_Q2_USD":-353046000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":73958000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":72850000.0,"StockholdersEquity_0_Q2_USD":1099167000.0,"Ticker":"SRPT","CIK":"873303","name":"SAREPTA THERAPEUTICS, INC.","OfficialName":"Sarepta Therapeutics Inc. Common Stock (DE)","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7117506934.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]